EIT Health

Catalyst Awardee

URIMON

Dr. Johan de Rooji, PhD, MBI & Mr. Bram de Moor, LLM, MBI | Amsterdam University Medical Center (NL) Technical University of Twente (NL); Mrs. Karin Oudshoorn, PhD; Dr. Marc Warmoes, PhD; Mrs. Maaike Dekker, MSc; Mr. Jeffrey Benistant, MSc; Mrs. Merel Enschot, MSc; Mr. Tintin Wongtana, BSc; Mr.…

Read More

---

Catalyst Awardee

PoliRNA: a new generation of targeted RNA therapies in cardiac regeneration

Letizia Nicoletti, PhD | Politecnico di Torino; Giovanni Paolo Stola, PhD Student; Valeria Chiono, Professor
Competition Sponsor: EIT Health
Awardee Year: 2025 PoliRNA is an innovative startup specialized in the development of customized nanocarriers for the next-generation of RNA therapies. With our cutting-edge polymer lipid hybrid nanocarriers, PoliRNA address…

Read More

---

Catalyst Awardee

HOPE

Prof. Philippe Karoyan, PhD | Centre National de la Recherche Scientifique, École Normale Supérieure – Paris Sciences & Lettres; Jonathan Levy, PharmD &MSc in Management; Jean-Pascal Tranié, Graduate of École Polytechnique and École Nationale d’Administration; Florence Allouche Aknin, PharmD & MBA; Luis Gomez Morales, PhD; Sterenn Goubin, DVM; Natasha…

Read More

---

Catalyst Awardee

Reprogramming Immunity: A 5th-Generation CAR-T Platform for Safer and More Durable Cancer Therapy

Dormeshkin Dmitri, PhD | Immunofusion; Alex Migas, PhD; Mikalai Katsin, MD
Competition Sponsor: EIT Health
Awardee Year: 2025

Immunofusion is a privately held biotech company committed to developing next-generation cell therapies that overcome the limitations of current CAR T technologies. While CAR T-cell therapies have transformed cancer and autoimmune

…

Read More

---

Catalyst Awardee

Galenband – Continuous arm-worn ECG

Oisín McGrath (Co-Founder) | Galenband; Eddie McDaid (Co-Founder)
Competition Sponsor: EIT Health
Awardee Year: 2025 Galenband is a Galway-based MedTech startup developing a groundbreaking wearable that captures ECG data continuously from the upper left arm for extended periods. The device fills a critical gap in atrial fibrillation detection, a…

Read More

---

Catalyst Awardee

AI-powered retinal screening for early detection of chronic diseases

Kyrylo Goncharuk, Founder & CEO | CHECK EYE LLC; Prof. Andrii Korol, MD, PhD – Founder & Chief Medical Director; Mykhailo Shuranov – Founder & Communications Advisor; Olena Chernenko – Strategic Healthcare Advisor; Anastasiia Kyrylenko – Head of Operations; Serhii Polienko – Head of Development; Victoria Chuchina – CMO…

Read More

---

Catalyst Awardee

Methica CC – accurate, fast, comfortable cervical cancer screening

Nutte van Belzen, MD | CC Diagnostics; Ronald Vos, BSc; Jolien de Waard, PhD; Ilinka Stanciu, MSc
Competition Sponsor: EIT Health
Awardee Year: 2025 CC Diagnostics aims to revolutionize cervical cancer screening. We have developed the Methica CC – a PCR-based test that detects damaged DNA that leads to…

Read More

---

Catalyst Awardee

Microneedle-Mediated, Targeted Fungal Infection Therapy to Preserve Mobility in Diabetic Patients

Waleed Faisal, PhD | ArrayPatch Ltd; Darren Cunningham
Competition Sponsor: EIT Health
Awardee Year: 2025  

ArrayPatch is pioneering a novel therapeutic platform using DerMap™ dissolving microneedles to deliver antifungal treatment directly into the nail bed and surrounding skin, targeting the $6 billion global onychomycosis (nail fungal infection) market.

…

Read More

---

Catalyst Awardee

EMOTION

Pr. Hafid Ait-Oufella | French National Institute of Health and Medical Research (INSERM); Mohamed ABOU ALI, PharmD; Tatiana MONSEUR, MsC Management; Vincent DUVAL, PhD; Rida Al-RIFAI, PharmD & PhD; Luna CHETRIT, PhD Student; Théo GUYON, Bachelor Research Biology Medical
Competition Sponsor: EIT Health of the European Union
Awardee Year: 2024…

Read More

---

Catalyst Awardee

Noory: Digital Nutrition Care as an Adjuvant to Standard Treatment

Jochem Bossenbroek, MSc, MBA | Verdify; Sandrin Bergheanu, MD, PhD; Fleur Pasman, BSc
Competition Sponsor: EIT Health of the European Union
Awardee Year: 2024 Nutrition care, as adjuvant to standard treatment, can potentially lead to 40% savings on healthcare cost in cancer, cardiovascular disease, obesity and other conditions (ESPEN,…

Read More

---